| 000 | 01245 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516035241.0 | ||
| 264 | 0 | _c20110601 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1102746 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Veldt, Astrid A M | |
| 245 | 0 | 0 |
_aAdvances in pancreatic neuroendocrine tumor treatment. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c05 2011 |
||
| 300 |
_a1873; author reply 1873-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aDiabetes Complications _xblood |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aNeuroendocrine Tumors _xdrug therapy |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aKleijn, Sebastiaan A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 364 _gno. 19 _gp. 1873; author reply 1873-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1102746 _zAvailable from publisher's website |
| 999 |
_c20824466 _d20824466 |
||